Cardiac monitoring system with supraventricular tachycardia (SVT) classifications
In one example, a cardiac monitoring system comprises a processor to receive a segment of an electrocardiogram (ECG) signal of a patient, and a memory to store the segment of the ECG. The processor is configured to identify QRS complexes in the segment of the ECG signal, generate a supraventricular (SV) template for SV complexes in the QRS complexes, identify SV complexes in the QRS complexes using the template, identify normal sinus rhythm (NSR) complexes in the segment of the ECG signal, obtain an atrial template for atrial waveforms in the NSR complexes, measure a range of a P-wave of the atrial waveforms from the NSR complexes, save the measured P-waves, and classify the identified SV complexes as either atrial fibrillation (AF) or supraventricular tachycardia (SVT) using the atrial template. Other examples and related methods are also disclosed herein.
1. A cardiac monitoring system, comprising:
a processor configured to receive a segment of an electrocardiogram (ECG) signal of a patient;
a memory to store the segment of the ECG;
wherein the processor is configured to:
identify normal sinus rhythm (NSR) complexes in the segment of the ECG signal as SV complexes;
measure RR intervals between consecutive pairs of the SV complexes;
determine RR variability from the measured RR intervals between consecutive pairs of the SV complexes;
obtain a P-wave waveform from a window of the corresponding SV complex for each of the RR intervals;
obtain a P-wave template from the P-wave waveforms in the SV complexes;
measure a range of the P-wave waveforms from the SV complexes;
save the measured range of P-waves, the P-wave waveforms, and the P-wave template in the memory; and
classify the identified SV complexes as either atrial fibrillation (AF) or supraventricular tachycardia (SVT) based at least on part the P-wave template and the RR variability;
wherein the identified SV complexes are classified as AF when the RR variability is greater than a threshold value and an amplitude of the P-wave template is below a predetermined percentage of the P-wave range measured during NSR; and
wherein the identified SV complexes are classified as SVT when the RR variability is higher than the threshold value and the amplitude of the P-wave template is above the predetermined percentage of the P-wave range; and
a support structure comprising a plurality of ECG electrodes configured to couple to a body of the patient through which the ECG signal of the patient is obtained;
wherein the support structure comprises a plurality of defibrillation electrodes configured to couple to the body of the patient, and a high voltage subsystem to apply a defibrillation voltage to the patient when a shockable event is detected by the processor based at least in part on the classification of the identified SV complexes.
2. The cardiac monitoring system of claim 1 , wherein:
the identified SV complexes are classified as atrial flutter (AFL) when the RR variability is high, and the RR intervals are integer multiples of a shortest one of the RR intervals.
3. The cardiac monitoring system of claim 1 , wherein the processor is further configured to:
analyze the P-wave waveforms for similarity when the RR variability is high; and
wherein the identified SV complexes are classified as Wenckebach when the P-wave waveforms are similar.
4. A cardioverter defibrillator, comprising:
a housing;
a processor in the housing configured to receive a segment of an electrocardiogram (ECG) signal of a patient;
a memory in the housing to store the segment of the ECG; and
a high voltage subsystem in the housing to apply a defibrillation voltage to the patient;
wherein the processor is configured to:
identify normal sinus rhythm (NSR) complexes in the segment of the ECG signal as SV complexes;
measure RR intervals between consecutive pairs of the SV complexes;
determine RR variability from the measured RR intervals between consecutive pairs of the SV complexes;
obtain a P-wave waveform from a window of the corresponding SV complex for each of the RR intervals;
obtain a P-wave template from the P-wave waveforms in the SV complexes;
measure a range of the P-wave waveforms from the SV complexes;
save the measured range of P-waves, the P-wave waveforms, and the P-wave template in the memory;
classify the identified SV complexes as either atrial fibrillation (AF) or supraventricular tachycardia (SVT) based at least on part the P-wave template and the RR variability;
wherein the identified SV complexes are classified as AF when the RR variability is greater than a threshold value and an amplitude of the P-wave template is below a predetermined percentage of the P-wave range measured during NSR; and
wherein the identified SV complexes are classified as SVT when the RR variability is higher than the threshold value and the amplitude of the P-wave template is above the predetermined percentage of the P-wave range; and
apply the defibrillation voltage to the patient when a shockable event is detected based at least in part on the classification of the identified SV complexes.
5. The cardioverter defibrillator of claim 4 , wherein the housing includes an adhesive and is affixable to a body of the patient via the adhesive.
6. The cardioverter defibrillator of claim 4 , wherein the housing is implantable in a subcutaneous location of a body of the patient.